U.S. federal trademark · Serial No. 90562136
Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at an individual's initial management timepoint
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.